KPV is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
KPV is typically reconstituted with bacteriostatic water (BAC water). The standard dosage of 200-500 mcg daily is administered once or twice daily via oral (most studied), intranasal, subcutaneous. Use our peptide calculator for exact mixing ratios.
How Do You Reconstitute KPV?
KPV is supplied as a lyophilized (freeze-dried) powder that must be reconstituted before use. Proper reconstitution is critical for accurate dosing and maintaining stability.
This guide covers the step-by-step process for mixing KPV with bacteriostatic water to achieve your target concentration.
What Supplies Do You Need?
To reconstitute KPV, you need: the KPV vial (lyophilized powder), bacteriostatic water (BAC water with 0.9% benzyl alcohol), insulin syringes (typically 1mL/100-unit), alcohol swabs, and a clean workspace.
Important: Always use bacteriostatic water — not sterile water or saline. BAC water's benzyl alcohol prevents bacterial contamination, extending the usable life of reconstituted KPV to 4-6 weeks.
Step-by-Step KPV Reconstitution
Step 1: Clean the vial tops of both the KPV and BAC water with alcohol swabs.
Step 2: Draw the calculated amount of BAC water into an insulin syringe. Use our peptide calculator to determine the exact amount.
Step 3: Insert the needle into the KPV vial at an angle, and let the water run down the side of the glass — never spray directly onto the powder as this can damage the peptide bonds.
Step 4: Gently swirl (do not shake) the vial until the powder is fully dissolved. The solution should be clear.
Step 5: Label the vial with the date and concentration. Store at 2-8°C.
Calculate Your KPV Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for KPV.
Open Calculator →How Do You Dose Reconstituted KPV?
After reconstitution, the standard KPV dose is 200-500 mcg daily administered once or twice daily via oral (most studied), intranasal, subcutaneous. The number of units on your insulin syringe depends on how much BAC water you added.
Our calculator will tell you exactly how many units to draw for your dose based on your specific reconstitution ratio.
How Do You Store Reconstituted KPV?
Store reconstituted KPV at 2-8°C (standard refrigerator temperature). Use within 4-6 weeks. Keep away from light and temperature fluctuations.
Unreconstituted KPV powder can be stored at -20°C for 12+ months. Once you reconstitute it, the clock starts.
Bottom Line
Reconstituting KPV is straightforward — add BAC water, swirl gently, refrigerate. The key is using the right amount of water for accurate dosing. Use our peptide calculator every time.
Complete Guide
KPV : Benefits, Dosage, Side Effects & Research
Related Reading
Research-Grade Sourcing
If you're going to research KPV, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is KPV?
KPV (Lysine-Proline-Valine tripeptide) is a Alpha-MSH fragment, NF-κB inhibitor. C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), naturally occurring from proteolytic cleavage. It is researched for anti-inflammatory, IBD reduction, intestinal barrier repair, skin inflammation reduction, immune modulation.
What is the recommended KPV dosage?
Common dosages: 200-500 mcg daily administered once or twice daily via oral (most studied), intranasal, subcutaneous. Cycle length: 4-8 weeks. Half-life: not published. Use our peptide calculator for exact reconstitution math.
What are the side effects of KPV?
No serious adverse events in preclinical studies. Theoretical potential for immune suppression at very high doses given NF-κB inhibition. GI upset possible with oral administration.
Is KPV safe?
KPV has shown a preliminary safety profile in research. Not FDA-approved. Expected to move from FDA Category 2 to Category 1 (allowing licensed compounding) based on 2026 regulatory developments. All research should follow appropriate safety protocols.